Exhibit 5.1
![LOGO](https://capedge.com/proxy/S-8/0001193125-20-181025/g944243g0626020038025.jpg)
| | |
June 26, 2020 | | ![LOGO](https://capedge.com/proxy/S-8/0001193125-20-181025/g9442431.jpg) |
Lantheus Holdings, Inc.
331 Treble Cove Road
North Billerica, Massachusetts 01862
Re: Registration Statement on FormS-8
Ladies and Gentlemen:
We have acted as counsel to Lantheus Holdings, Inc., a corporation organized under the laws of Delaware (“Lantheus Holdings”), in connection with the preparation and filing with the Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933 (the “Securities Act”) of Lantheus Holdings’ Registration Statement on FormS-8 (the “Registration Statement,” which term does not include any other document or agreement whether or not specifically referred to or incorporated by reference therein or attached as an exhibit or schedule thereto), relating to up to 4,211,290 shares of Lantheus Holdings’ common stock, par value $0.01 per share (the “Lantheus Holdings Shares”), to be issued by Lantheus Holdings from time to time to holders of certain options granted under the Lantheus Holdings, Inc. 2018 Performance Incentive Plan (f/k/a Progenics Pharmaceuticals, Inc. 2018 Performance Incentive Plan), as amended, and the Lantheus Holdings, Inc. 2005 Stock Incentive Plan (f/k/a Progenics Pharmaceuticals, Inc. 2005 Stock Incentive Plan), as amended (collectively, the “Plans”), which were converted pursuant to that certain Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of February 20, 2020, by and among Lantheus Holdings, Plato Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Lantheus Holdings, and Progenics Pharmaceuticals, Inc., a Delaware corporation.
In connection with our opinions expressed below, we have examined originals or copies certified to our satisfaction of the following documents and such other documents, certificates and other statements of government officials and corporate officers of Lantheus Holdings as we deemed necessary for the purposes of the opinions set forth in this opinion letter: (i) the Registration Statement in the form to be filed with the SEC on the date hereof, (ii) the Merger Agreement, (iii) the certificate of merger filed with the Secretary of State of Delaware in connection with the Merger Agreement, (iv) the Plans, (v) Lantheus Holdings’ Amended and Restated Certificate of Incorporation, (vi) Lantheus Holdings’ Amended and Restated Bylaws and (vii) a form of the share certificate, which has been incorporated by reference as an exhibit to the Registration Statement. We have also examined the originals, or duplicative or certificated or conformed copies, of such corporate records, agreements, documents and other instruments and have made such other investigations as we have deemed relevant and necessary in connection with this opinion letter. As to questions of fact material to this opinion letter, we have relied, with your approval, upon oral and written representations of Lantheus Holdings and certificates or comparable documents of public officials and of officers and representatives of Lantheus Holdings.